Trial · NCT00720356
Participant flow14
How many started, completed or left each group, period by period.
1 to 14 of 14
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Registration to Study | STARTED | Erlotinib and Bevacizumab Combination Treatment | 115 | |
| Registration to Study | Completed Registration Step 1 | Erlotinib and Bevacizumab Combination Treatment | 115 | |
| Registration to Study | Completed Registration Step 2 | Erlotinib and Bevacizumab Combination Treatment | 48 | |
| Registration to Study | COMPLETED | Erlotinib and Bevacizumab Combination Treatment | 48 | |
| Registration to Study | NOT COMPLETED | Erlotinib and Bevacizumab Combination Treatment | 67 | |
| Reached 1st Response/2 Cycles | STARTED | Erlotinib and Bevacizumab Combination Treatment | 48 | |
| Reached 1st Response/2 Cycles | COMPLETED | Erlotinib and Bevacizumab Combination Treatment | 46 | |
| Reached 1st Response/2 Cycles | NOT COMPLETED | Erlotinib and Bevacizumab Combination Treatment | 2 | |
| Went on to be Treated Cycle 3 | STARTED | Erlotinib and Bevacizumab Combination Treatment | 46 | |
| Went on to be Treated Cycle 3 | COMPLETED | Erlotinib and Bevacizumab Combination Treatment | 44 | |
| Went on to be Treated Cycle 3 | NOT COMPLETED | Erlotinib and Bevacizumab Combination Treatment | 2 | |
| Follow up Until Death | STARTED | Erlotinib and Bevacizumab Combination Treatment | 48 | |
| Follow up Until Death | COMPLETED | Erlotinib and Bevacizumab Combination Treatment | 43 | |
| Follow up Until Death | NOT COMPLETED | Erlotinib and Bevacizumab Combination Treatment | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00720356/flow